Supriya Lifescience Limited (SUPRIYA) — Cash Flow Quality Index
Supriya Lifescience Limited (SUPRIYA) has a Cash Flow Quality Index of 0.65x as of September 2025. Operating cash flow of Rs555.65 Million is below net income of Rs852.17 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow conversion of Supriya Lifescience Limited to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Supriya Lifescience Limited Cash Flow Quality Index (2018–2025)
Historical Cash Flow Quality Index for Supriya Lifescience Limited across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check SUPRIYA total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Supriya Lifescience Limited (2018–2025)
Year-by-year earnings quality comparison for Supriya Lifescience Limited. For live market cap and the full company financial profile, see Supriya Lifescience Limited (SUPRIYA) total market value.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.92x | Rs1.73 Billion | Rs1.88 Billion | ▼ -3.5% |
| 2024 | 0.95x | Rs1.13 Billion | Rs1.19 Billion | ▲ +77.5% |
| 2023 | 0.54x | Rs661.87 Million | Rs1.23 Billion | ▲ +127.6% |
| 2022 | 0.24x | Rs488.01 Million | Rs2.07 Billion | ▼ -50.7% |
| 2021 | 0.48x | Rs799.30 Million | Rs1.67 Billion | ▼ -60.4% |
| 2020 | 1.21x | Rs1.16 Billion | Rs962.27 Million | ▲ +41.5% |
| 2019 | 0.85x | Rs486.72 Million | Rs571.04 Million | ▼ -57.4% |
| 2018 | 2.00x | Rs174.52 Million | Rs87.28 Million | — |